{\rtf1\ansi\deff0
{\fonttbl
{\f1\fcharset2 Symbol;}{\f00\fcharset0 Arial;}
{\f10\fcharset0 Times New Roman;}
{\f12\fcharset204 Times New Roman;}
}
{\colortbl;\red0\green0\blue0;\red255\green255\blue255;\red0\green0\blue255;}
{\stylesheet{\f0;}
}
{\info{\upr{\author????????????}
{\*\ud\uc0{\author{\uc1\u77u\u97u\u114u\u99u\u111u\u115u\u32u\u68u\u243u\u115u\u101u\u97u}
}
}
}
{\upr{\keywords???????????????????????}
{\*\ud\uc0{\keywords{\uc1\u67u\u114u\u101u\u97u\u116u\u101u\u100u\u66u\u121u\u73u\u82u\u73u\u83u\u95u\u68u\u80u\u69u\u95u\u49u\u50u\u46u\u48u\u51u}
}
}
}
{\creatim\yr2014\mo10\dy13\hr23\min01}
}
\viewkind1\splytwnine\ftnlytwnine\htmautsp\nolnhtadjtbl\useltbaln\alntblind\lytcalctblwd\lyttblrtgr\lnbrkrule\nobrkwrptbl\snaptogridincell\allowfieldendsel\ApplyBrkRules\wrppunct\asianbrkrule\rsidroot6310308\newtblstyruls\nogrowautofit\paperh16840\paperw11907\margl729\margr3637\margb360\margt4958\pard\li0{\pict\picwgoal7507\pichgoal1344\pngblip
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}
\par\pard\lang1046\li39\ri4804\sb72\ql\fi0\sl-244\f00 \fs18\cbpat2{\fs18\charscalex91\b0\i\ul0\cf1\chcbpat2\f00 Domínio \fs18\charscalex73\i0\f10 7 7: \fs18\charscalex91\i\f00 Segurança/proteção \line Classe \fs20\charscalex100\i0\f10 5: \fs18\charscalex91\i\f00 Processos defensivos \par}
\pard
\pard\lang1046\li39\ri38\sb115\ql\fi0\sl-240\f10 \fs20\cbpat2{\fs20\charscalex118\b\i0\ul0\cf1\chcbpat2\f10 Definição \charscalex100\b0 Risco de resposta nociva ou não intencional, associada a uso de meio de \line contraste com iodo, que pode ocorrer dentro de sete (7) dias após a injeção do meio \line de contraste. \par}
\pard
\sbknone\sect\pard\sectd\fs24\sl-321\par\pard\sbknone\sect\pard{\shp{
\shpleft7661\shptop7622\shpright8409\shpbottom9177\shpwr2\shpbymargin\shpbxmargin{\sp{\sn shapeType}
{\sv 75}
}
{\sp{\sn fBehindDocument}
{\sv 1}
}
{\sp{\sn pWrapPolygonVertices}
{\sv 8;4;(21477,0);(0,0);(0,21497);(21477,21497)}
}
{\sp{\sn posrelh}
{\sv 0}
}
{\sp{\sn posrelv}
{\sv 0}
}
{\sp{\sn pib}
{\sv{\pict\picwgoal748\pichgoal1555\pngblip
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}
}
}
}
}
\pard\sl-1\ls2\par\pard\phmrg\pvmrg\posx58\posy8217\absw7483\absh2524\dfrmtxtx120\dfrmtxty120\lang1046\li19\ri4\ql\fi0\sl-163\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 American College of Radiology. (2008). \fs15\i Manual \fs15\i0 on \fs15\i contrast media \fs15\i0 (version 6). Reston, VA: \fs15 Author, \par}
\pard
\pard\phmrg\pvmrg\posx58\posy8217\absw7483\absh2524\dfrmtxtx120\dfrmtxty120\lang1046\li14\ri19\sb62\ql\fi0\sl-182\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Bellin, M., Jakobsen, J., Tomassin, L, Thomsen, H.S., \fs13\charscalex112\f00 & \fs15\charscalex100\f10 Morcos, S.K. (2002). Contrast medium extravasation \line injury: Guidelines for prevention and management. \fs15\i European Radiology, \fs15\i0 12(11), 2807-2812. \par}
\pard
\pard\phmrg\pvmrg\posx58\posy8217\absw7483\absh2524\dfrmtxtx120\dfrmtxty120\lang1046\li19\ri4\ql\fi0\sl-163\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Bettmann, M.A. (2004). Frequently asked questions: Iodinated contrast agents. \fs15\i Radiographics, \fs15\i0 24 (Special Issue), \line S3-S10. \par}
\pard
\pard\phmrg\pvmrg\posx58\posy8217\absw7483\absh2524\dfrmtxtx120\dfrmtxty120\lang1046\li19\ri14\sb52\ql\fi0\sl-187\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Brockow, K., Christiansen, \fs18\charscalex90\f00 c., \fs15\charscalex100\f10 Kanny, G., Clément, O., Barbaud, A., Bircher, A. et aI.; ENDA EAACI Interest Group \line on Drug Hypersensitivity. (2005). Management of hypersensitivity reactions to iodinated contrast media. \fs15\i Allergy, \line 60(2), 150-158. \par}
\pard
\pard\phmrg\pvmrg\posx58\posy8217\absw7483\absh2524\dfrmtxtx120\dfrmtxty120\lang1046\li19\ri4\ql\fi0\sl-163\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Cohan, R.H., Ellis, J.H., \fs14\charscalex112\f00 & \fs15\charscalex100\f10 Garner, WL. (1996). Extravasation of radiographic contrast material: Recognition, \line prevenríon, and treatment. \fs15\i Radiology, 200(3),593-604. \par}
\pard
\pard\phmrg\pvmrg\posx58\posy8217\absw7483\absh2524\dfrmtxtx120\dfrmtxty120\lang1046\li19\ri4\ql\fi0\sl-163\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Costa, N. (2004). Understanding contrast media. \fs15\i Journal of Infusion Nursing, \fs15\i0 27(5), 302-312. European Society \line of Urogenital Radiology. (2007). \fs15\i ESUR Guidelines \fs15\i0 on \fs15\i contrast media \fs15\i0 (version 6). Heidelberg: Springer-Verlag. \par}
\pard
\cols2\colno1\colw3609\colsr350\colno2\colw3537\colsr0\pard\lang1046\li62\ri-1\ql\fi0\sl-235\f00 \fs20\cbpat2{\fs20\charscalex114\b\i0\ul0\cf1\chcbpat2\f00 Fatores de risco \par}
\pard
\pard\lang1046\li321\ri-1\ql\fi-268\sl-345\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Ansiedade \par\pard}
\pard
\pard\lang1046\li336\ri8\ql\fi-283\sl-230\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Debilidade generalizada \par\pard}
\pard
\pard\lang1046\li336\ri8\ql\fi-283\sl-230\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Desidratação \par\pard}
\pard
\pard\lang1046\li336\ri8\ql\fi-283\sl-230\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Doença subjacente (p. ex., doença \line cardíaca, doença pulmonar, discrasias \line do sangue, doença endócrina, doença \line renal, feocromocitoma, doença \line autoimune) \par\pard}
\pard
\pard\lang1046\li336\ri8\ql\fi-283\sl-230\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Extremos de idade \par\pard}
\pard
\pard\lang1046\li336\ri8\ql\fi-283\sl-230\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 História de alergias \par\pard}
\pard
\pard\lang1046\li340\ri200\ql\fi-278\sl-235\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 História de efeito adverso anterior \line com meio de contraste com iodo \par\pard}
\pard
\pard\lang1046\li336\ri8\ql\fi-283\sl-230\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Inconsciência \par\pard}
\pard
\pard\lang1046\li340\ri200\ql\fi-278\sl-235\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Propriedades físicas e químicas \line dos meios de contraste (p. ex., \line concentração de iodo, viscosidade, \par\pard}
\pard
\pard\lang1046\li72\ri-1\sb528\ql\fi0\sl-235\f00 \fs20\cbpat2{\fs20\charscalex114\b\i0\ul0\cf1\chcbpat2\f00 Referências \par}
\pard
\column\pard\sl-1\fs2\par\pard\pard\lang1046\li278\ri287\sb340\ql\fi0\sl-235\f10 \fs20\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 alta osmolalidade, toxicidade por \line íons) \par}
\pard
\pard\lang1046\li288\ri8\ql\fi-283\sl-230\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Uso concomitante de medicamentos \line (p. ex., betabloqueadores, \line interleucina - 2, metformina, \line medicamentos nefrotóxicos) \par\pard}
\pard
\pard\lang1046\li288\ri8\ql\fi-283\sl-230\f10 \fs20{\pntext\pard\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2 •\tab}
{\*\pn\pnlvlblt\pnf1\pnstart-1\pncf1\chcbpat2{\pntxtb\'B7}
}
\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Veias fragilizadas (p. ex., tratamento \line anterior ou presente com quimiote- \line rapia ou radioterapia no membro \par\pard}
\pard
\pard\lang1046\li288\ri95\sb4\ql\fi0\sl-240\f10 \fs20\cbpat2{\fs20\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 a ser injetado, múltiplas tentativas \line de obtenção de acesso intravenoso, \line cateter intravenoso de demora \line deixado no local por mais de 24 \line horas, dissecção anterior de nódulo \line linfático axilar no membro a ser \line injetado, locais distais de acesso \line intravenoso: mão, pulso, pé, torno- \line zelo) \par}
\pard
\sbknone\sect\pard\sectd\fs24\sl-297\par\pard\sbknone\sect\pard\pard\lang1046\li4872\ql\fi0\sl-278\f10 \fs15\cbpat2{\fs15\charscalex100\b0\i0\ul0\cf1\chcbpat2\f10 Classe 5: Processos defensivos \fs25\charscalex106\b\f00 531 \par}
\pard
\sbknone\sect\pard\sectd}
